The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Synthetic Hormones Market Research Report 2025

Global Synthetic Hormones Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1801612

No of Pages : 109

Synopsis
Synthetic hormones are foreign molecules that are produced in a laboratory and used to cure hormonal imbalances in men and women. Synthetic hormones such as progesterone, estrogen, thyroid hormone, testosterone, and insulin are commonly utilized to treat a variety of medical problems. These hormones are extremely active even at low doses, and long-term usage of synthetic hormones has been related to a variety of adverse effects. Some synthetic hormones on the market include Ferring B.V.'s Zomacton injectable (Somatropin), which is used to treat growth hormone insufficiency in children.
Global Synthetic Hormones market is projected to reach US$ 270.8 million in 2029, increasing from US$ 214 million in 2022, with the CAGR of 3.6% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Synthetic Hormones market research.
The synthetic hormones market refers to the segment of the pharmaceutical industry that focuses on the development, production, and sale of synthetic or artificially produced hormones. Synthetic hormones are designed to mimic the effects of naturally occurring hormones in the body. Synthetic hormones play a crucial role in various medical treatments and therapies. They are used for a range of purposes, including hormone replacement therapy (HRT), contraception, fertility treatments, and management of hormonal disorders. Common synthetic hormones include estrogen, progesterone, testosterone, and various forms of birth control hormones. The market for synthetic hormones has witnessed significant growth in recent years due to several factors. One of the key drivers is the increasing prevalence of hormonal imbalances and disorders, such as menopause, polycystic ovary syndrome (PCOS), and hypogonadism. Additionally, the growing aging population and the increasing interest in anti-aging treatments have also contributed to the market expansion. Advancements in the field of biotechnology and pharmaceutical research have led to the development of advanced synthetic hormone formulations, including sustained-release formulations and combination therapies. These innovations offer improved efficacy, convenience, and patient compliance, further driving the market growth. The market is characterized by the presence of both generic and branded synthetic hormone products. Generic drugs are usually more affordable, leading to their widespread adoption, especially in developing regions. However, branded products continue to dominate the market in developed countries due to their brand recognition, marketing strategies, and perceived quality.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Synthetic Hormones market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Pfizer, Inc.
McGuff Pharmaceuticals, Inc.
Lyndra Therapeutics, Inc.
Ferring B. V.
Slayback Pharma
Lupin Pharmaceuticals, Inc.
Acerus Pharmaceuticals Corporation
IBSA Institut Biochimique SA
Endo International plc
American Reagent, Inc.
Merck Serono
Novo Nordisk
F. Hoffmann-La Roche
BioPartners
Eli Lilly
Segment by Type
Steroid Hormones
Peptide Hormone
Amino Acid Derivatives
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Synthetic Hormones report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Index
1 Synthetic Hormones Market Overview
1.1 Product Overview and Scope of Synthetic Hormones
1.2 Synthetic Hormones Segment by Type
1.2.1 Global Synthetic Hormones Market Value Comparison by Type (2023-2029)
1.2.2 Steroid Hormones
1.2.3 Peptide Hormone
1.2.4 Amino Acid Derivatives
1.3 Synthetic Hormones Segment by Application
1.3.1 Global Synthetic Hormones Market Value by Application: (2023-2029)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Global Synthetic Hormones Market Size Estimates and Forecasts
1.4.1 Global Synthetic Hormones Revenue 2018-2029
1.4.2 Global Synthetic Hormones Sales 2018-2029
1.4.3 Global Synthetic Hormones Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Synthetic Hormones Market Competition by Manufacturers
2.1 Global Synthetic Hormones Sales Market Share by Manufacturers (2018-2023)
2.2 Global Synthetic Hormones Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Synthetic Hormones Average Price by Manufacturers (2018-2023)
2.4 Global Synthetic Hormones Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Synthetic Hormones, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Synthetic Hormones, Product Type & Application
2.7 Synthetic Hormones Market Competitive Situation and Trends
2.7.1 Synthetic Hormones Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Synthetic Hormones Players Market Share by Revenue
2.7.3 Global Synthetic Hormones Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Synthetic Hormones Retrospective Market Scenario by Region
3.1 Global Synthetic Hormones Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Synthetic Hormones Global Synthetic Hormones Sales by Region: 2018-2029
3.2.1 Global Synthetic Hormones Sales by Region: 2018-2023
3.2.2 Global Synthetic Hormones Sales by Region: 2024-2029
3.3 Global Synthetic Hormones Global Synthetic Hormones Revenue by Region: 2018-2029
3.3.1 Global Synthetic Hormones Revenue by Region: 2018-2023
3.3.2 Global Synthetic Hormones Revenue by Region: 2024-2029
3.4 North America Synthetic Hormones Market Facts & Figures by Country
3.4.1 North America Synthetic Hormones Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Synthetic Hormones Sales by Country (2018-2029)
3.4.3 North America Synthetic Hormones Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Synthetic Hormones Market Facts & Figures by Country
3.5.1 Europe Synthetic Hormones Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Synthetic Hormones Sales by Country (2018-2029)
3.5.3 Europe Synthetic Hormones Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Synthetic Hormones Market Facts & Figures by Country
3.6.1 Asia Pacific Synthetic Hormones Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Synthetic Hormones Sales by Country (2018-2029)
3.6.3 Asia Pacific Synthetic Hormones Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Synthetic Hormones Market Facts & Figures by Country
3.7.1 Latin America Synthetic Hormones Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Synthetic Hormones Sales by Country (2018-2029)
3.7.3 Latin America Synthetic Hormones Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Synthetic Hormones Market Facts & Figures by Country
3.8.1 Middle East and Africa Synthetic Hormones Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Synthetic Hormones Sales by Country (2018-2029)
3.8.3 Middle East and Africa Synthetic Hormones Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Synthetic Hormones Sales by Type (2018-2029)
4.1.1 Global Synthetic Hormones Sales by Type (2018-2023)
4.1.2 Global Synthetic Hormones Sales by Type (2024-2029)
4.1.3 Global Synthetic Hormones Sales Market Share by Type (2018-2029)
4.2 Global Synthetic Hormones Revenue by Type (2018-2029)
4.2.1 Global Synthetic Hormones Revenue by Type (2018-2023)
4.2.2 Global Synthetic Hormones Revenue by Type (2024-2029)
4.2.3 Global Synthetic Hormones Revenue Market Share by Type (2018-2029)
4.3 Global Synthetic Hormones Price by Type (2018-2029)
5 Segment by Application
5.1 Global Synthetic Hormones Sales by Application (2018-2029)
5.1.1 Global Synthetic Hormones Sales by Application (2018-2023)
5.1.2 Global Synthetic Hormones Sales by Application (2024-2029)
5.1.3 Global Synthetic Hormones Sales Market Share by Application (2018-2029)
5.2 Global Synthetic Hormones Revenue by Application (2018-2029)
5.2.1 Global Synthetic Hormones Revenue by Application (2018-2023)
5.2.2 Global Synthetic Hormones Revenue by Application (2024-2029)
5.2.3 Global Synthetic Hormones Revenue Market Share by Application (2018-2029)
5.3 Global Synthetic Hormones Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Pfizer, Inc.
6.1.1 Pfizer, Inc. Corporation Information
6.1.2 Pfizer, Inc. Description and Business Overview
6.1.3 Pfizer, Inc. Synthetic Hormones Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Pfizer, Inc. Synthetic Hormones Product Portfolio
6.1.5 Pfizer, Inc. Recent Developments/Updates
6.2 McGuff Pharmaceuticals, Inc.
6.2.1 McGuff Pharmaceuticals, Inc. Corporation Information
6.2.2 McGuff Pharmaceuticals, Inc. Description and Business Overview
6.2.3 McGuff Pharmaceuticals, Inc. Synthetic Hormones Sales, Revenue and Gross Margin (2018-2023)
6.2.4 McGuff Pharmaceuticals, Inc. Synthetic Hormones Product Portfolio
6.2.5 McGuff Pharmaceuticals, Inc. Recent Developments/Updates
6.3 Lyndra Therapeutics, Inc.
6.3.1 Lyndra Therapeutics, Inc. Corporation Information
6.3.2 Lyndra Therapeutics, Inc. Description and Business Overview
6.3.3 Lyndra Therapeutics, Inc. Synthetic Hormones Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Lyndra Therapeutics, Inc. Synthetic Hormones Product Portfolio
6.3.5 Lyndra Therapeutics, Inc. Recent Developments/Updates
6.4 Ferring B. V.
6.4.1 Ferring B. V. Corporation Information
6.4.2 Ferring B. V. Description and Business Overview
6.4.3 Ferring B. V. Synthetic Hormones Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Ferring B. V. Synthetic Hormones Product Portfolio
6.4.5 Ferring B. V. Recent Developments/Updates
6.5 Slayback Pharma
6.5.1 Slayback Pharma Corporation Information
6.5.2 Slayback Pharma Description and Business Overview
6.5.3 Slayback Pharma Synthetic Hormones Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Slayback Pharma Synthetic Hormones Product Portfolio
6.5.5 Slayback Pharma Recent Developments/Updates
6.6 Lupin Pharmaceuticals, Inc.
6.6.1 Lupin Pharmaceuticals, Inc. Corporation Information
6.6.2 Lupin Pharmaceuticals, Inc. Description and Business Overview
6.6.3 Lupin Pharmaceuticals, Inc. Synthetic Hormones Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Lupin Pharmaceuticals, Inc. Synthetic Hormones Product Portfolio
6.6.5 Lupin Pharmaceuticals, Inc. Recent Developments/Updates
6.7 Acerus Pharmaceuticals Corporation
6.6.1 Acerus Pharmaceuticals Corporation Corporation Information
6.6.2 Acerus Pharmaceuticals Corporation Description and Business Overview
6.6.3 Acerus Pharmaceuticals Corporation Synthetic Hormones Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Acerus Pharmaceuticals Corporation Synthetic Hormones Product Portfolio
6.7.5 Acerus Pharmaceuticals Corporation Recent Developments/Updates
6.8 IBSA Institut Biochimique SA
6.8.1 IBSA Institut Biochimique SA Corporation Information
6.8.2 IBSA Institut Biochimique SA Description and Business Overview
6.8.3 IBSA Institut Biochimique SA Synthetic Hormones Sales, Revenue and Gross Margin (2018-2023)
6.8.4 IBSA Institut Biochimique SA Synthetic Hormones Product Portfolio
6.8.5 IBSA Institut Biochimique SA Recent Developments/Updates
6.9 Endo International plc
6.9.1 Endo International plc Corporation Information
6.9.2 Endo International plc Description and Business Overview
6.9.3 Endo International plc Synthetic Hormones Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Endo International plc Synthetic Hormones Product Portfolio
6.9.5 Endo International plc Recent Developments/Updates
6.10 American Reagent, Inc.
6.10.1 American Reagent, Inc. Corporation Information
6.10.2 American Reagent, Inc. Description and Business Overview
6.10.3 American Reagent, Inc. Synthetic Hormones Sales, Revenue and Gross Margin (2018-2023)
6.10.4 American Reagent, Inc. Synthetic Hormones Product Portfolio
6.10.5 American Reagent, Inc. Recent Developments/Updates
6.11 Merck Serono
6.11.1 Merck Serono Corporation Information
6.11.2 Merck Serono Synthetic Hormones Description and Business Overview
6.11.3 Merck Serono Synthetic Hormones Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Merck Serono Synthetic Hormones Product Portfolio
6.11.5 Merck Serono Recent Developments/Updates
6.12 Novo Nordisk
6.12.1 Novo Nordisk Corporation Information
6.12.2 Novo Nordisk Synthetic Hormones Description and Business Overview
6.12.3 Novo Nordisk Synthetic Hormones Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Novo Nordisk Synthetic Hormones Product Portfolio
6.12.5 Novo Nordisk Recent Developments/Updates
6.13 F. Hoffmann-La Roche
6.13.1 F. Hoffmann-La Roche Corporation Information
6.13.2 F. Hoffmann-La Roche Synthetic Hormones Description and Business Overview
6.13.3 F. Hoffmann-La Roche Synthetic Hormones Sales, Revenue and Gross Margin (2018-2023)
6.13.4 F. Hoffmann-La Roche Synthetic Hormones Product Portfolio
6.13.5 F. Hoffmann-La Roche Recent Developments/Updates
6.14 BioPartners
6.14.1 BioPartners Corporation Information
6.14.2 BioPartners Synthetic Hormones Description and Business Overview
6.14.3 BioPartners Synthetic Hormones Sales, Revenue and Gross Margin (2018-2023)
6.14.4 BioPartners Synthetic Hormones Product Portfolio
6.14.5 BioPartners Recent Developments/Updates
6.15 Eli Lilly
6.15.1 Eli Lilly Corporation Information
6.15.2 Eli Lilly Synthetic Hormones Description and Business Overview
6.15.3 Eli Lilly Synthetic Hormones Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Eli Lilly Synthetic Hormones Product Portfolio
6.15.5 Eli Lilly Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Synthetic Hormones Industry Chain Analysis
7.2 Synthetic Hormones Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Synthetic Hormones Production Mode & Process
7.4 Synthetic Hormones Sales and Marketing
7.4.1 Synthetic Hormones Sales Channels
7.4.2 Synthetic Hormones Distributors
7.5 Synthetic Hormones Customers
8 Synthetic Hormones Market Dynamics
8.1 Synthetic Hormones Industry Trends
8.2 Synthetic Hormones Market Drivers
8.3 Synthetic Hormones Market Challenges
8.4 Synthetic Hormones Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’